RituxiRel™
Brand Name: RituxiRel™
Active Ingredient (Composition): Rituximab (500 mg)
Manufacturer: Reliance Life Sciences
Product Description
Medical Info
RituxiRel™ is a prescription-only, anticancer medication classified as a monoclonal antibody. It is primarily used to treat various conditions, including blood cancers like Non-Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). Additionally, it is prescribed for autoimmune and inflammatory disorders such as rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis. The medication works by targeting and binding to the CD20 antigen found on the surface of B-lymphocytes, triggering their destruction to manage disease progression. RituxiRel™ must be administered as an intravenous (I.V.) infusion by a qualified healthcare professional in a clinical setting.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
